SynthesisBMJ open2018
Quality indicators for responsible use of medicines: a systematic review.
Synthesis in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Quality indicators for safe and effective use of medications in long-term care settings: A systematic review.British journal of clinical pharmacology · 2025Pooled it
- Pharmaceutical Care Network Europe definition of quality indicators for pharmaceutical care: a systematic literature review and international consensus development.International journal of clinical pharmacy · 2024Pooled it
- Quality Assessment of Services in Primary Healthcare in Iran: A Systematic Review and Meta-analysis.Ethiopian journal of health sciences · 2022Pooled it
- Does drug dispensing improve the health outcomes of patients attending community pharmacies? A systematic review.BMC health services research · 2021Pooled it
- Primary health care quality indicators: An umbrella review.PloS one · 2019Pooled it
- Quality indicators for safe and effective medication use in long-term care facilities: A modified Delphi study.British journal of clinical pharmacology · 2026Article
- Quality indicators for opioid stewardship interventions in hospital inpatient and emergency departments: a systematic review.Pain reports · 2025Review
- An Evaluation of Drug Prescribing Patterns and Prescription Completeness.Healthcare (Basel, Switzerland) · 2024Article
- Sex differences in cardiologic medication provision for adults with coronary heart disease: an analysis of health claims data from 2018 to 2020 in Saxony-Anhalt, Germany.BMC health services research · 2024Article
- Quality indicators for appropriate antibiotic prescribing in urinary tract infections in children.BMC infectious diseases · 2023Review
- Validation of quality indicators for evaluating geriatric pharmacotherapy services in primary care: a mixed methods study.BMJ open · 2023Observational
- Polypharmacy and precision medicine.Cambridge prisms. Precision medicine · 2023Review
- Community Health Nurses' Perspective on the Introduced Rational Drug Use Policy in Primary Care Settings in Thailand: A Descriptive Qualitative Study.Tropical medicine and infectious disease · 2022Article
- Development and consensus testing of quality indicators for geriatric pharmacotherapy in primary care using a modified Delphi study.International journal of clinical pharmacy · 2022Article
- What Should Be Considered When Evaluating the Quality of Home Care? A Survey of Expert Opinions on the Evaluation of the Quality of Home Care in Japan.International journal of environmental research and public health · 2022Article
- Irrational Use of Medicine in the Treatment of Presumptive Asthma Among Rural Primary Care Providers in Southwestern China.Frontiers in pharmacology · 2022Article
- Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions.International journal of general medicine · 2021Review
- Developing Iranian primary health care quality framework: a national study.BMC public health · 2019Review
- Patient Safety: A Deep Concern to Caregivers.Innovations in pharmacy · 2019Article
- Focus and features of prescribing indications spanning multiple chronic conditions in older adults: A narrative review.Journal of multimorbidity and comorbidityReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAll healthcare systems require valid ways to evaluate service delivery. The objective of this study was to identify existing content validated quality indicators (QIs) for responsible use of medicines (RUM) and classify them using multiple frameworks to identify gaps in current quality measurements.
designSystematic review without meta-analysis.
settingAll care settings. SEARCH STRATEGY: CINAHL, Embase, Global Health, International Pharmaceutical Abstract, MEDLINE, PubMed and Web of Science databases were searched up to April 2018. An internet search was also conducted. Articles were included if they described medication-related QIs developed using consensus methods. Government agency websites listing QIs for RUM were also included. ANALYSIS: Several multidimensional frameworks were selected to assess the scope of QI coverage. These included Donabedian's framework (structure, process and outcome), the Anatomical Therapeutic Chemical (ATC) classification system and a validated classification for causes of drug-related problems (c-DRPs; drug selection, drug form, dose selection, treatment duration, drug use process, logistics, monitoring, adverse drug reactions and others).
results2431 content validated QIs were identified from 131 articles and 5 websites. Using Donabedian's framework, the majority of QIs were process indicators. Based on the ATC code, the largest number of QIs pertained to medicines for nervous system (ATC code: N), followed by anti-infectives for systemic use (J) and cardiovascular system (C). The most common c-DRPs pertained to 'drug selection', followed by 'monitoring' and 'drug use process'.
conclusionsThis study was the first systematic review classifying QIs for RUM using multiple frameworks. The list of the identified QIs can be used as a database for evaluating the achievement of RUM. Although many QIs were identified, this approach allowed for the identification of gaps in quality measurement of RUM. In order to more effectively evaluate the extent to which RUM has been achieved, further development of QIs may be required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.